Tandem Diabetes Care, Inc.
TNDM
Rank in Stocks
#7685
Tandem Diabetes Care, Inc., a medical technology firm, specializes in creating,... Tandem Diabetes Care, Inc., a medical technology firm, specializes in creating, developing, and marketing solutions for individuals globally who manage insulin-dependent diabetes. At the core of its offerings is the t:slim X2 insulin delivery system, an advanced pump platform that integrates the t:slim X2 pump, a disposable 300-unit insulin cartridge, and an infusion set. Tandem further enhances this platform with innovative features like Basal-IQ and Control-IQ technology, as well as G5 Integration capabilities. The company also provides the Tandem Device Updater, enabling users to easily update their pump's software. To facilitate therapy management, Tandem offers t:connect, a web-based application that visually presents diabetes data from the pump, continuous glucose monitoring (CGM) devices, and supported blood glucose meters to patients, their caregivers, and healthcare professionals. Additionally, the Sugarmate mobile application caters specifically to insulin users with diabetes. Tandem has strategic development and commercialization partnerships with leading companies such as Dexcom, Inc. and Abbott Laboratories. Established in 2006 and headquartered in San Diego, California, the company was initially known as Phluid Inc. before rebranding as Tandem Diabetes Care, Inc. in January 2008.
Share Price
$18.17
Last synced: 2026-11-09
Market Cap
$1.26B
Change (1 day)
7.45%
Change (1 year)
3.71%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Tandem Diabetes Care, Inc. (TNDM)
Category
Healthcare
Operating Margin for Tandem Diabetes Care, Inc. (TNDM)
Operating Margin as of November 2026 TTM: -4.13%
According to Tandem Diabetes Care, Inc.'s latest financial reports, its current operating margin (TTM) is -4.13%. At the end of 2025 the company had an operating margin of -7.70%.
Operating Margin history for Tandem Diabetes Care, Inc. from 2011 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -4.13% | -46.36% |
| 2025 | -7.70% | -26.94% |
| 2024 | -10.54% | -66.21% |
| 2023 | -31.19% | 169.11% |
| 2022 | -11.59% | -459.94% |
| 2021 | 3.22% | -301.25% |
| 2020 | -1.60% | -65.37% |
| 2019 | -4.62% | -80.96% |
| 2018 | -24.27% | -58.51% |
| 2017 | -58.50% | -36.85% |
| 2016 | -92.64% | -2.20% |
| 2015 | -94.72% | -37.75% |
| 2014 | -152.17% | -10.71% |
| 2013 | -170.42% | -87.24% |
| 2012 | -1,335.44% | 0.00% |
| 2011 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -103.69% |
US
|
|
| 18.08% | -104.38% |
IE
|
|
| 21.25% | -105.15% |
US
|
|
| 21.05% | -105.10% |
US
|
|
| 28.09% | -106.80% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Tandem Diabetes Care, Inc.'s operating margin
What is Tandem Diabetes Care, Inc.'s operating margin?
Tandem Diabetes Care, Inc.'s operating margin is -4.13%, as of Nov 2026.
What was Tandem Diabetes Care, Inc.'s operating margin in 2025?
In 2025, Tandem Diabetes Care, Inc.'s operating margin was -7.70%, compared with -10.54% in 2024.
How has Tandem Diabetes Care, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Tandem Diabetes Care, Inc.'s operating margin was highest in 2021 (3.22%) and lowest in 2023 (-31.19%).
How does Tandem Diabetes Care, Inc.'s operating margin compare with similar companies?
Tandem Diabetes Care, Inc.'s operating margin (-4.13%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.